Spectrum of chronic lung allograft pathology in a mouse minor‐mismatched orthotopic lung transplant model

Chronic lung allograft dysfunction (CLAD) is a fatal condition that limits survival after lung transplantation (LTx). The pathological hallmark of CLAD is obliterative bronchiolitis (OB). A subset of patients present with a more aggressive CLAD phenotype, called restrictive allograft syndrome (RAS), characterized by lung parenchymal fibrosis (PF). The mouse orthotopic single LTx model has proven relevant to the mechanistic study of allograft injury. The minor‐alloantigen‐mismatched strain combination using C57BL/10(B10) donors and C57BL/6(B6) recipients reportedly leads to OB. Recognizing that OB severity is a spectrum that may coexist with other pathologies, including PF, we aimed to characterize and quantify pathologic features of CLAD in this model. Left LTx was performed in the following combinations: B10→B6, B6→B10, B6→B6. Four weeks posttransplant, blinded pathologic semi‐quantitative assessment showed that OB was present in 66% of B10→B6 and 30% of B6→B10 grafts. Most mice with OB also had PF with a pattern of pleuroparenchymal fibroelastosis, reminiscent of human RAS‐related pathology. Grading of pathologic changes demonstrated variable severity of airway fibrosis, PF, acute rejection, vascular fibrosis, and epithelial changes, similar to those seen in human CLAD. These assessments can make the murine LTx model a more useful tool for further mechanistic studies of CLAD pathogenesis.

[1]  S. Ensminger Chronic Airway Fibrosis in Orthotopic Mouse Lung Transplantation Models-An Experimental Reappraisal? , 2017, Transplantation.

[2]  D. Kenkel,et al.  Chronic Airway Fibrosis in Orthotopic Mouse Lung Transplantation Models—An Experimental Reappraisal , 2017, Transplantation.

[3]  G. Verleden,et al.  A New Step in the Marathon of Understanding Chronic Rejection after Lung Transplantation. , 2017, American journal of respiratory cell and molecular biology.

[4]  Pawan Kumar Gupta,et al.  IL‐17A Blockade Attenuates Obliterative Bronchiolitis and IFN‐&ggr; Cellular Immune Response in Lung Allografts , 2017, American journal of respiratory cell and molecular biology.

[5]  Pawan Kumar Gupta,et al.  Th17 cells are not required for maintenance of IL-17A producing γδ T cells in vivo , 2016, Immunology and cell biology.

[6]  S. Keshavjee,et al.  Halofuginone treatment reduces interleukin-17A and ameliorates features of chronic lung allograft dysfunction in a mouse orthotopic lung transplant model. , 2016, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[7]  D. Kreisel,et al.  The Role of Lymphoid Neogenesis in Allografts , 2016, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[8]  Pawan Kumar Gupta,et al.  CD4 T Cells but Not Th17 Cells Are Required for Mouse Lung Transplant Obliterative Bronchiolitis , 2015, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[9]  B. Murdock,et al.  Local origin of mesenchymal cells in a murine orthotopic lung transplantation model of bronchiolitis obliterans. , 2015, The American journal of pathology.

[10]  G. Verleden,et al.  A new classification system for chronic lung allograft dysfunction. , 2014, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[11]  L. Snyder,et al.  Impact of forced vital capacity loss on survival after the onset of chronic lung allograft dysfunction. , 2014, American journal of respiratory and critical care medicine.

[12]  E. Mickler,et al.  Role of Complement Activation in Obliterative Bronchiolitis Post–Lung Transplantation , 2013, The Journal of Immunology.

[13]  L. Lund,et al.  The Registry of the International Society for Heart and Lung Transplantation: Thirtieth Adult Lung and Heart-Lung Transplant Report--2013; focus theme: age. , 2013, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[14]  Henrik Westerberg,et al.  A comparative phenotypic and genomic analysis of C57BL/6J and C57BL/6N mouse strains , 2013, Genome Biology.

[15]  G. Verleden,et al.  Neutrophilic Reversible Allograft Dysfunction (NRAD) and Restrictive Allograft Syndrome (RAS) , 2013, Seminars in Respiratory and Critical Care Medicine.

[16]  M. Sato,et al.  Lentivirus IL‐10 Gene Therapy Down‐Regulates IL‐17 and Attenuates Mouse Orthotopic Lung Allograft Rejection , 2013, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[17]  O. Cummings,et al.  IL-17 induces type V collagen overexpression and EMT via TGF-β-dependent pathways in obliterative bronchiolitis. , 2013, American journal of physiology. Lung cellular and molecular physiology.

[18]  S. Keshavjee,et al.  Restrictive allograft syndrome post lung transplantation is characterized by pleuroparenchymal fibroelastosis , 2013, Modern Pathology.

[19]  J. Eu,et al.  Epithelial Clara Cell Injury Occurs in Bronchiolitis Obliterans Syndrome After Human Lung Transplantation , 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[20]  G. Verleden,et al.  Chronic Rejection Pathology after Orthotopic Lung Transplantation in Mice: The Development of a Murine BOS Model and Its Drawbacks , 2012, PloS one.

[21]  S. Keshavjee,et al.  Restrictive allograft syndrome (RAS): a novel form of chronic lung allograft dysfunction. , 2011, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[22]  E. Mickler,et al.  Neutralizing IL‐17 Prevents Obliterative Bronchiolitis in Murine Orthotopic Lung Transplantation , 2011, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[23]  S. Keshavjee,et al.  The Role of Intrapulmonary De Novo Lymphoid Tissue in Obliterative Bronchiolitis after Lung Transplantation1 , 2009, The Journal of Immunology.

[24]  D. Kreisel,et al.  A Mouse Model of Orthotopic Vascularized Aerated Lung Transplantation , 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[25]  Gerald J Berry,et al.  Revision of the 1996 working formulation for the standardization of nomenclature in the diagnosis of lung rejection. , 2005, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.